“Credo fermamente che EXOGEN mi abbia cambiato radicalmente la vita.”
Rimasta gravemente ferita in un incidente stradale, Angela Jones si è trovata di fronte a una prognosi particolarmente desolante. Il suo tallone destro era rimasto così schiacciato che, a un certo punto, i medici le dissero che avrebbero dovuto amputare il piede. Angela ha iniziato a sentirsi più fiduciosa dopo l’intervento di ricostruzione del tallone, e ancora di più dopo che un’amica le ha parlato di EXOGEN. Dopo aver consultato il suo chirurgo ortopedico, Angela ha iniziato a usare EXOGEN e i risultati sono stati straordinari.
Questo video racconto è rappresentativo di un’indicazione approvata dalla FDA statunitense per l’uso di EXOGEN.
Esclusione di responsabilità: le informazioni presentate nelle testimonianze dei pazienti sono rappresentative esclusivamente dell’esperienza specifica del paziente e non costituiscono consigli medici.
Summary of Indications for Use
The EXOGEN Ultrasound Bone Healing System is indicated for the non-invasive treatment of established nonunions* excluding skull and vertebra. The EXOGEN device has also been reported as effective as an adjunctive non-invasive treatment of established nonunions in patients:
- With internal or external fracture fixation hardware present. EXOGEN cannot penetrate metal and therefore should not be applied directly over hardware.
- Undergoing treatment for infection at the fracture site. EXOGEN is not intended to treat the infection.
- Believed to have diminished bone quality. EXOGEN is not intended to treat diminished bone quality.
In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopedically managed by closed reduction and cast immobilization.
There are no known contraindications for the EXOGEN device. Safety and effectiveness have not been established for individuals lacking skeletal maturity, pregnant or nursing women, patients with cardiac pacemakers, on fractures due to bone cancer, or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel.
*A nonunion is considered to be established when the fracture site shows no visibly progressive signs of healing.
Full prescribing information can be found in product labelling, at EXOGEN.com, or by calling Customer Service at 1-800-836-4080.